These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1364024)

  • 1. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
    Nair SP; Sen AK
    Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the immune responses of sheep against foot-and-mouth disease virus types Asia-1 and O PEG-concentrated aluminium hydroxide gel and oil-adjuvanted vaccines.
    Nair SP; Sen AK
    Vaccine; 1993; 11(7):782-6. PubMed ID: 8393608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
    Morgan DO; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses of sheep against inactivated foot-and-mouth disease PEG concentrated aluminium hydroxide gel vaccines.
    Nair SP; Sen AK
    Trop Anim Health Prod; 1994 Nov; 26(4):255-7. PubMed ID: 7900227
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
    Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D).
    de Leeuw PW; Tiessink JW; Frenkel S
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):85-97. PubMed ID: 231355
    [No Abstract]   [Full Text] [Related]  

  • 14. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
    Song X; Bao S; Wu L; Hu S
    Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.
    Hunter P
    Rev Sci Tech; 1996 Sep; 15(3):913-22. PubMed ID: 9025141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency testing of foot--and--mouth disease vaccines prepared from strain "C" with different adjuvants.
    Sólyom F; Fazekas A; Czelleng F; Makár A; Roith J
    Dev Biol Stand; 1976; 35():113-5. PubMed ID: 198276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.